FUSION PROTEINS WITH HALF LIFE EXTENDING DOMAINS

The invention relates to a fusion protein that comprises at least one albumin binding moiety and further comprises a tumor targeting moiety. The invention relates to the use of the fusion proteins or of compositions comprising the fusion proteins for medical applications. L'invention concerne u...

Full description

Saved in:
Bibliographic Details
Main Authors HOFFMANN, Gregor, BOSSE-DOENECKE, Eva, HAUPTS, Ulrich, GLOSER-BRAEUNIG, Manja
Format Patent
LanguageEnglish
French
Published 04.01.2024
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention relates to a fusion protein that comprises at least one albumin binding moiety and further comprises a tumor targeting moiety. The invention relates to the use of the fusion proteins or of compositions comprising the fusion proteins for medical applications. L'invention concerne une protéine de fusion qui comprend au moins une fraction de liaison à l'albumine et qui comprend en outre une fraction de ciblage de tumeur. L'invention concerne l'utilisation des protéines de fusion ou de compositions comprenant les protéines de fusion pour des applications médicales.
Bibliography:Application Number: WO2023EP68109